peptide elongation factor 2 has been researched along with Atypical Ductal Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braunstein, S; Connolly, E; Formenti, S; Schneider, RJ | 1 |
1 other study(ies) available for peptide elongation factor 2 and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Blotting, Western; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Cycle Proteins; Cell Line, Transformed; Cell Line, Tumor; Enzyme Activation; Female; Gene Silencing; Humans; Hypoxia; Methionine; Peptide Elongation Factor 2; Phosphoproteins; Phosphorylation; Precipitin Tests; Protein Kinases; Retroviridae; Ribosomal Protein S6 Kinases; RNA Interference; RNA, Small Interfering; Signal Transduction; Sulfur Radioisotopes; TOR Serine-Threonine Kinases | 2006 |